nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—SLCO2B1—Montelukast—allergic rhinitis	0.125	0.188	CbGbCtD
Erlotinib—CYP1B1—Dexamethasone—allergic rhinitis	0.0373	0.0561	CbGbCtD
Erlotinib—CYP1A2—Desloratadine—allergic rhinitis	0.0368	0.0553	CbGbCtD
Erlotinib—ABCB1—Desloratadine—allergic rhinitis	0.0322	0.0484	CbGbCtD
Erlotinib—CYP2D6—Desloratadine—allergic rhinitis	0.0303	0.0456	CbGbCtD
Erlotinib—ABCG2—Hydrocortisone—allergic rhinitis	0.0285	0.0429	CbGbCtD
Erlotinib—CYP2C8—Montelukast—allergic rhinitis	0.0273	0.041	CbGbCtD
Erlotinib—CYP2C8—Loratadine—allergic rhinitis	0.0273	0.041	CbGbCtD
Erlotinib—CYP1A2—Diphenhydramine—allergic rhinitis	0.0211	0.0318	CbGbCtD
Erlotinib—CYP3A4—Flunisolide—allergic rhinitis	0.0193	0.029	CbGbCtD
Erlotinib—ABCB1—Loratadine—allergic rhinitis	0.0185	0.0278	CbGbCtD
Erlotinib—CYP3A4—Olopatadine—allergic rhinitis	0.0181	0.0273	CbGbCtD
Erlotinib—ABCG2—Dexamethasone—allergic rhinitis	0.0177	0.0267	CbGbCtD
Erlotinib—CYP2D6—Loratadine—allergic rhinitis	0.0174	0.0262	CbGbCtD
Erlotinib—CYP2D6—Diphenhydramine—allergic rhinitis	0.0174	0.0262	CbGbCtD
Erlotinib—ABCB1—Methylprednisolone—allergic rhinitis	0.0169	0.0254	CbGbCtD
Erlotinib—CYP1A1—Dexamethasone—allergic rhinitis	0.0164	0.0246	CbGbCtD
Erlotinib—CYP3A5—Hydrocortisone—allergic rhinitis	0.0158	0.0237	CbGbCtD
Erlotinib—CYP2C8—Hydrocortisone—allergic rhinitis	0.0152	0.0228	CbGbCtD
Erlotinib—CYP3A4—Loratadine—allergic rhinitis	0.0111	0.0166	CbGbCtD
Erlotinib—CYP3A4—Montelukast—allergic rhinitis	0.0111	0.0166	CbGbCtD
Erlotinib—ABCB1—Betamethasone—allergic rhinitis	0.011	0.0165	CbGbCtD
Erlotinib—ABCB1—Prednisolone—allergic rhinitis	0.0108	0.0163	CbGbCtD
Erlotinib—ABCB1—Hydrocortisone—allergic rhinitis	0.0103	0.0155	CbGbCtD
Erlotinib—CYP3A4—Methylprednisolone—allergic rhinitis	0.0101	0.0152	CbGbCtD
Erlotinib—CYP3A5—Dexamethasone—allergic rhinitis	0.00983	0.0148	CbGbCtD
Erlotinib—CYP2C8—Dexamethasone—allergic rhinitis	0.00945	0.0142	CbGbCtD
Erlotinib—CYP3A4—Triamcinolone—allergic rhinitis	0.00768	0.0115	CbGbCtD
Erlotinib—ABL2—Signaling by Robo receptor—PFN2—allergic rhinitis	0.00671	0.153	CbGpPWpGaD
Erlotinib—CYP3A4—Betamethasone—allergic rhinitis	0.00659	0.0099	CbGbCtD
Erlotinib—CYP3A4—Prednisolone—allergic rhinitis	0.0065	0.00977	CbGbCtD
Erlotinib—ABCB1—Dexamethasone—allergic rhinitis	0.00639	0.00961	CbGbCtD
Erlotinib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00616	0.00926	CbGbCtD
Erlotinib—CYP2D6—Dexamethasone—allergic rhinitis	0.00603	0.00906	CbGbCtD
Erlotinib—ORM1—saliva—allergic rhinitis	0.00452	0.0657	CbGeAlD
Erlotinib—CYP3A4—Dexamethasone—allergic rhinitis	0.00383	0.00576	CbGbCtD
Erlotinib—MAP3K19—respiratory system—allergic rhinitis	0.00283	0.0411	CbGeAlD
Erlotinib—FLT3—respiratory system—allergic rhinitis	0.00245	0.0357	CbGeAlD
Erlotinib—ABL1—Signaling by Robo receptor—PFN2—allergic rhinitis	0.00237	0.0539	CbGpPWpGaD
Erlotinib—TNK1—bronchus—allergic rhinitis	0.00235	0.0342	CbGeAlD
Erlotinib—TNK1—trachea—allergic rhinitis	0.00211	0.0307	CbGeAlD
Erlotinib—LTK—lung—allergic rhinitis	0.00207	0.03	CbGeAlD
Erlotinib—ULK3—eye—allergic rhinitis	0.00193	0.0281	CbGeAlD
Erlotinib—PIP4K2C—bronchus—allergic rhinitis	0.00182	0.0265	CbGeAlD
Erlotinib—MKNK1—eye—allergic rhinitis	0.00182	0.0265	CbGeAlD
Erlotinib—ULK3—bronchus—allergic rhinitis	0.00174	0.0253	CbGeAlD
Erlotinib—JAK3—IL2 signaling events mediated by STAT5—FOXP3—allergic rhinitis	0.00167	0.0379	CbGpPWpGaD
Erlotinib—JAK3—lung—allergic rhinitis	0.00165	0.024	CbGeAlD
Erlotinib—STK10—respiratory system—allergic rhinitis	0.00164	0.0239	CbGeAlD
Erlotinib—MKNK1—bronchus—allergic rhinitis	0.00164	0.0238	CbGeAlD
Erlotinib—PIP4K2C—trachea—allergic rhinitis	0.00164	0.0238	CbGeAlD
Erlotinib—ULK3—trachea—allergic rhinitis	0.00156	0.0227	CbGeAlD
Erlotinib—SLK—bronchus—allergic rhinitis	0.00155	0.0226	CbGeAlD
Erlotinib—TNK1—lung—allergic rhinitis	0.00152	0.022	CbGeAlD
Erlotinib—MAP3K19—lung—allergic rhinitis	0.0015	0.0218	CbGeAlD
Erlotinib—SLK—trachea—allergic rhinitis	0.00139	0.0203	CbGeAlD
Erlotinib—STK10—bronchus—allergic rhinitis	0.00135	0.0196	CbGeAlD
Erlotinib—FLT3—lung—allergic rhinitis	0.0013	0.0189	CbGeAlD
Erlotinib—JAK3—Interleukin receptor SHC signaling—IL5—allergic rhinitis	0.00129	0.0293	CbGpPWpGaD
Erlotinib—ABL2—lung—allergic rhinitis	0.00124	0.0181	CbGeAlD
Erlotinib—EGFR—lung—allergic rhinitis	0.00121	0.0177	CbGeAlD
Erlotinib—MAP2K5—bronchus—allergic rhinitis	0.00121	0.0175	CbGeAlD
Erlotinib—PIP4K2C—lung—allergic rhinitis	0.00118	0.0171	CbGeAlD
Erlotinib—SLCO2B1—respiratory system—allergic rhinitis	0.00114	0.0166	CbGeAlD
Erlotinib—ABL1—respiratory system—allergic rhinitis	0.00113	0.0164	CbGeAlD
Erlotinib—ULK3—lung—allergic rhinitis	0.00112	0.0163	CbGeAlD
Erlotinib—MAP2K5—trachea—allergic rhinitis	0.00108	0.0157	CbGeAlD
Erlotinib—MKNK1—lung—allergic rhinitis	0.00106	0.0154	CbGeAlD
Erlotinib—ABL2—Axon guidance—PFN2—allergic rhinitis	0.00105	0.0239	CbGpPWpGaD
Erlotinib—ABL1—eye—allergic rhinitis	0.00103	0.015	CbGeAlD
Erlotinib—JAK3—IL4-mediated signaling events—CCL11—allergic rhinitis	0.00101	0.023	CbGpPWpGaD
Erlotinib—SLK—lung—allergic rhinitis	0.001	0.0146	CbGeAlD
Erlotinib—CYP1B1—respiratory system—allergic rhinitis	0.000957	0.0139	CbGeAlD
Erlotinib—ABL1—bronchus—allergic rhinitis	0.00093	0.0135	CbGeAlD
Erlotinib—ABL1—skin of body—allergic rhinitis	0.000898	0.0131	CbGeAlD
Erlotinib—JAK3—Interleukin-3, 5 and GM-CSF signaling—IL5—allergic rhinitis	0.000897	0.0204	CbGpPWpGaD
Erlotinib—EPHA6—Axon guidance—PFN2—allergic rhinitis	0.000889	0.0202	CbGpPWpGaD
Erlotinib—CYP1B1—eye—allergic rhinitis	0.000874	0.0127	CbGeAlD
Erlotinib—STK10—lung—allergic rhinitis	0.000871	0.0127	CbGeAlD
Erlotinib—JAK3—IL2 signaling events mediated by STAT5—IL4—allergic rhinitis	0.000867	0.0197	CbGpPWpGaD
Erlotinib—JAK3—Interleukin-2 signaling—IL5—allergic rhinitis	0.000851	0.0193	CbGpPWpGaD
Erlotinib—JAK3—G beta:gamma signalling through PI3Kgamma—IL5—allergic rhinitis	0.000837	0.019	CbGpPWpGaD
Erlotinib—ABL1—trachea—allergic rhinitis	0.000835	0.0121	CbGeAlD
Erlotinib—JAK3—GPVI-mediated activation cascade—IL5—allergic rhinitis	0.000823	0.0187	CbGpPWpGaD
Erlotinib—JAK3—G-protein beta:gamma signalling—IL5—allergic rhinitis	0.000797	0.0181	CbGpPWpGaD
Erlotinib—MAP2K5—lung—allergic rhinitis	0.000778	0.0113	CbGeAlD
Erlotinib—CYP1B1—skin of body—allergic rhinitis	0.000761	0.0111	CbGeAlD
Erlotinib—ABL2—Developmental Biology—PFN2—allergic rhinitis	0.000752	0.0171	CbGpPWpGaD
Erlotinib—JAK3—CD40/CD40L signaling—IL4—allergic rhinitis	0.000749	0.017	CbGpPWpGaD
Erlotinib—CYP1A2—respiratory system—allergic rhinitis	0.000686	0.00997	CbGeAlD
Erlotinib—JAK3—IL4-mediated signaling events—IL5—allergic rhinitis	0.000682	0.0155	CbGpPWpGaD
Erlotinib—CYP1A1—respiratory system—allergic rhinitis	0.000677	0.00984	CbGeAlD
Erlotinib—CYP3A5—respiratory system—allergic rhinitis	0.000662	0.00962	CbGeAlD
Erlotinib—EPHA6—Developmental Biology—PFN2—allergic rhinitis	0.000634	0.0144	CbGpPWpGaD
Erlotinib—ORM1—lung—allergic rhinitis	0.000632	0.00918	CbGeAlD
Erlotinib—SLCO2B1—lung—allergic rhinitis	0.000605	0.0088	CbGeAlD
Erlotinib—ABL1—lung—allergic rhinitis	0.0006	0.00872	CbGeAlD
Erlotinib—CYP1A1—epithelium—allergic rhinitis	0.000565	0.00822	CbGeAlD
Erlotinib—CYP1A1—bronchus—allergic rhinitis	0.000557	0.0081	CbGeAlD
Erlotinib—JAK3—IL-4 Signaling Pathway—IL4—allergic rhinitis	0.000542	0.0123	CbGpPWpGaD
Erlotinib—CYP1A1—skin of body—allergic rhinitis	0.000538	0.00782	CbGeAlD
Erlotinib—CYP1B1—lung—allergic rhinitis	0.000508	0.00739	CbGeAlD
Erlotinib—CYP1A1—trachea—allergic rhinitis	0.0005	0.00727	CbGeAlD
Erlotinib—JAK3—IL4-mediated signaling events—IL10—allergic rhinitis	0.000499	0.0113	CbGpPWpGaD
Erlotinib—JAK3—IL4-mediated signaling events—IL4—allergic rhinitis	0.000485	0.011	CbGpPWpGaD
Erlotinib—JAK3—Signaling by Interleukins—IL5—allergic rhinitis	0.000438	0.00994	CbGpPWpGaD
Erlotinib—MKNK1—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	0.000404	0.00918	CbGpPWpGaD
Erlotinib—ABCG2—lung—allergic rhinitis	0.000378	0.0055	CbGeAlD
Erlotinib—JAK3—CD40/CD40L signaling—NFKB1—allergic rhinitis	0.000377	0.00857	CbGpPWpGaD
Erlotinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—SMAD3—allergic rhinitis	0.000375	0.00853	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—PFN2—allergic rhinitis	0.000372	0.00846	CbGpPWpGaD
Erlotinib—JAK3—IL2 signaling events mediated by PI3K—NFKB1—allergic rhinitis	0.000369	0.00838	CbGpPWpGaD
Erlotinib—CYP1A2—lung—allergic rhinitis	0.000364	0.00529	CbGeAlD
Erlotinib—CYP1A1—lung—allergic rhinitis	0.000359	0.00522	CbGeAlD
Erlotinib—ABCB1—respiratory system—allergic rhinitis	0.000351	0.00511	CbGeAlD
Erlotinib—CYP3A5—lung—allergic rhinitis	0.000351	0.00511	CbGeAlD
Erlotinib—EGFR—Axon guidance—PFN2—allergic rhinitis	0.000318	0.00723	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000296	0.00673	CbGpPWpGaD
Erlotinib—ABCB1—epithelium—allergic rhinitis	0.000294	0.00427	CbGeAlD
Erlotinib—JAK3—IL-4 Signaling Pathway—NFKB1—allergic rhinitis	0.000273	0.00619	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—PFN2—allergic rhinitis	0.000265	0.00603	CbGpPWpGaD
Erlotinib—ABCB1—trachea—allergic rhinitis	0.00026	0.00378	CbGeAlD
Erlotinib—JAK3—Cytokine Signaling in Immune system—HLA-G—allergic rhinitis	0.000253	0.00576	CbGpPWpGaD
Erlotinib—Acute coronary syndrome—Prednisolone—allergic rhinitis	0.00025	0.00113	CcSEcCtD
Erlotinib—Hypokalaemia—Betamethasone—allergic rhinitis	0.00025	0.00113	CcSEcCtD
Erlotinib—Hypokalaemia—Dexamethasone—allergic rhinitis	0.00025	0.00113	CcSEcCtD
Erlotinib—Neuropathy peripheral—Prednisolone—allergic rhinitis	0.000248	0.00112	CcSEcCtD
Erlotinib—Myocardial infarction—Prednisolone—allergic rhinitis	0.000248	0.00112	CcSEcCtD
Erlotinib—Infestation—Hydrocortisone—allergic rhinitis	0.000247	0.00111	CcSEcCtD
Erlotinib—Infestation NOS—Hydrocortisone—allergic rhinitis	0.000247	0.00111	CcSEcCtD
Erlotinib—JAK3—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000247	0.00561	CbGpPWpGaD
Erlotinib—Pruritus—Cetirizine—allergic rhinitis	0.000247	0.00111	CcSEcCtD
Erlotinib—Conjunctivitis—Prednisolone—allergic rhinitis	0.000246	0.00111	CcSEcCtD
Erlotinib—Asthenia—Flunisolide—allergic rhinitis	0.000246	0.00111	CcSEcCtD
Erlotinib—Dizziness—Loratadine—allergic rhinitis	0.000245	0.0011	CcSEcCtD
Erlotinib—Acute coronary syndrome—Hydrocortisone—allergic rhinitis	0.000244	0.0011	CcSEcCtD
Erlotinib—Myocardial infarction—Hydrocortisone—allergic rhinitis	0.000243	0.00109	CcSEcCtD
Erlotinib—Neuropathy peripheral—Hydrocortisone—allergic rhinitis	0.000243	0.00109	CcSEcCtD
Erlotinib—Pruritus—Flunisolide—allergic rhinitis	0.000242	0.00109	CcSEcCtD
Erlotinib—Gastrointestinal pain—Montelukast—allergic rhinitis	0.000239	0.00108	CcSEcCtD
Erlotinib—Diarrhoea—Cetirizine—allergic rhinitis	0.000238	0.00107	CcSEcCtD
Erlotinib—Vomiting—Loratadine—allergic rhinitis	0.000235	0.00106	CcSEcCtD
Erlotinib—JAK3—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	0.000235	0.00534	CbGpPWpGaD
Erlotinib—Diarrhoea—Flunisolide—allergic rhinitis	0.000234	0.00106	CcSEcCtD
Erlotinib—Rash—Loratadine—allergic rhinitis	0.000234	0.00105	CcSEcCtD
Erlotinib—Dermatitis—Loratadine—allergic rhinitis	0.000233	0.00105	CcSEcCtD
Erlotinib—Infestation NOS—Methylprednisolone—allergic rhinitis	0.000232	0.00105	CcSEcCtD
Erlotinib—Infestation—Methylprednisolone—allergic rhinitis	0.000232	0.00105	CcSEcCtD
Erlotinib—Headache—Loratadine—allergic rhinitis	0.000232	0.00105	CcSEcCtD
Erlotinib—Body temperature increased—Montelukast—allergic rhinitis	0.000231	0.00104	CcSEcCtD
Erlotinib—Abdominal pain—Montelukast—allergic rhinitis	0.000231	0.00104	CcSEcCtD
Erlotinib—Dizziness—Cetirizine—allergic rhinitis	0.00023	0.00104	CcSEcCtD
Erlotinib—Acute coronary syndrome—Triamcinolone—allergic rhinitis	0.00023	0.00103	CcSEcCtD
Erlotinib—Acute coronary syndrome—Methylprednisolone—allergic rhinitis	0.000229	0.00103	CcSEcCtD
Erlotinib—Haemoglobin—Prednisolone—allergic rhinitis	0.000229	0.00103	CcSEcCtD
Erlotinib—Myocardial infarction—Triamcinolone—allergic rhinitis	0.000228	0.00103	CcSEcCtD
Erlotinib—Neuropathy peripheral—Triamcinolone—allergic rhinitis	0.000228	0.00103	CcSEcCtD
Erlotinib—ABL1—Regulation of Telomerase—SMAD3—allergic rhinitis	0.000228	0.00519	CbGpPWpGaD
Erlotinib—Neuropathy peripheral—Methylprednisolone—allergic rhinitis	0.000228	0.00103	CcSEcCtD
Erlotinib—Myocardial infarction—Methylprednisolone—allergic rhinitis	0.000228	0.00103	CcSEcCtD
Erlotinib—Haemorrhage—Prednisolone—allergic rhinitis	0.000227	0.00102	CcSEcCtD
Erlotinib—EGFR—Developmental Biology—PFN2—allergic rhinitis	0.000227	0.00516	CbGpPWpGaD
Erlotinib—Dizziness—Flunisolide—allergic rhinitis	0.000227	0.00102	CcSEcCtD
Erlotinib—Conjunctivitis—Triamcinolone—allergic rhinitis	0.000226	0.00102	CcSEcCtD
Erlotinib—Haemoglobin—Hydrocortisone—allergic rhinitis	0.000223	0.00101	CcSEcCtD
Erlotinib—Haemorrhage—Hydrocortisone—allergic rhinitis	0.000222	0.001	CcSEcCtD
Erlotinib—Vomiting—Cetirizine—allergic rhinitis	0.000222	0.000998	CcSEcCtD
Erlotinib—Nausea—Loratadine—allergic rhinitis	0.00022	0.000991	CcSEcCtD
Erlotinib—Epistaxis—Triamcinolone—allergic rhinitis	0.00022	0.00099	CcSEcCtD
Erlotinib—Rash—Cetirizine—allergic rhinitis	0.00022	0.00099	CcSEcCtD
Erlotinib—Dermatitis—Cetirizine—allergic rhinitis	0.00022	0.000989	CcSEcCtD
Erlotinib—MAP2K5—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000219	0.00498	CbGpPWpGaD
Erlotinib—Headache—Cetirizine—allergic rhinitis	0.000218	0.000984	CcSEcCtD
Erlotinib—Connective tissue disorder—Hydrocortisone—allergic rhinitis	0.000218	0.000984	CcSEcCtD
Erlotinib—Vomiting—Flunisolide—allergic rhinitis	0.000218	0.000982	CcSEcCtD
Erlotinib—Rash—Flunisolide—allergic rhinitis	0.000216	0.000974	CcSEcCtD
Erlotinib—Dermatitis—Flunisolide—allergic rhinitis	0.000216	0.000973	CcSEcCtD
Erlotinib—Headache—Flunisolide—allergic rhinitis	0.000215	0.000967	CcSEcCtD
Erlotinib—Weight decreased—Dexamethasone—allergic rhinitis	0.000214	0.000967	CcSEcCtD
Erlotinib—Weight decreased—Betamethasone—allergic rhinitis	0.000214	0.000967	CcSEcCtD
Erlotinib—Haemoglobin—Triamcinolone—allergic rhinitis	0.00021	0.000947	CcSEcCtD
Erlotinib—Haemoglobin—Methylprednisolone—allergic rhinitis	0.00021	0.000945	CcSEcCtD
Erlotinib—Asthenia—Montelukast—allergic rhinitis	0.00021	0.000945	CcSEcCtD
Erlotinib—Haemorrhage—Triamcinolone—allergic rhinitis	0.000209	0.000942	CcSEcCtD
Erlotinib—Haemorrhage—Methylprednisolone—allergic rhinitis	0.000209	0.00094	CcSEcCtD
Erlotinib—Acute coronary syndrome—Dexamethasone—allergic rhinitis	0.000208	0.000939	CcSEcCtD
Erlotinib—Acute coronary syndrome—Betamethasone—allergic rhinitis	0.000208	0.000939	CcSEcCtD
Erlotinib—Eye disorder—Hydrocortisone—allergic rhinitis	0.000208	0.000935	CcSEcCtD
Erlotinib—Neuropathy peripheral—Betamethasone—allergic rhinitis	0.000207	0.000934	CcSEcCtD
Erlotinib—Myocardial infarction—Betamethasone—allergic rhinitis	0.000207	0.000934	CcSEcCtD
Erlotinib—Myocardial infarction—Dexamethasone—allergic rhinitis	0.000207	0.000934	CcSEcCtD
Erlotinib—Neuropathy peripheral—Dexamethasone—allergic rhinitis	0.000207	0.000934	CcSEcCtD
Erlotinib—Nausea—Cetirizine—allergic rhinitis	0.000207	0.000933	CcSEcCtD
Erlotinib—Pruritus—Montelukast—allergic rhinitis	0.000207	0.000932	CcSEcCtD
Erlotinib—Conjunctivitis—Betamethasone—allergic rhinitis	0.000205	0.000926	CcSEcCtD
Erlotinib—Conjunctivitis—Dexamethasone—allergic rhinitis	0.000205	0.000926	CcSEcCtD
Erlotinib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	0.000205	0.000924	CcSEcCtD
Erlotinib—JAK3—Cytokine Signaling in Immune system—IL5—allergic rhinitis	0.000204	0.00464	CbGpPWpGaD
Erlotinib—Nausea—Flunisolide—allergic rhinitis	0.000204	0.000917	CcSEcCtD
Erlotinib—Arrhythmia—Prednisolone—allergic rhinitis	0.000203	0.000916	CcSEcCtD
Erlotinib—CYP1B1—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000201	0.00457	CbGpPWpGaD
Erlotinib—Diarrhoea—Montelukast—allergic rhinitis	0.0002	0.000901	CcSEcCtD
Erlotinib—EGFR—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.0002	0.00454	CbGpPWpGaD
Erlotinib—Arrhythmia—Hydrocortisone—allergic rhinitis	0.000198	0.000894	CcSEcCtD
Erlotinib—Erythema—Prednisolone—allergic rhinitis	0.000198	0.000892	CcSEcCtD
Erlotinib—EGFR—Regulation of Telomerase—SMAD3—allergic rhinitis	0.000195	0.00443	CbGpPWpGaD
Erlotinib—Eye disorder—Methylprednisolone—allergic rhinitis	0.000195	0.000879	CcSEcCtD
Erlotinib—Mental disorder—Hydrocortisone—allergic rhinitis	0.000195	0.000877	CcSEcCtD
Erlotinib—Malnutrition—Hydrocortisone—allergic rhinitis	0.000193	0.000871	CcSEcCtD
Erlotinib—Erythema—Hydrocortisone—allergic rhinitis	0.000193	0.000871	CcSEcCtD
Erlotinib—Dizziness—Montelukast—allergic rhinitis	0.000193	0.000871	CcSEcCtD
Erlotinib—Haemoglobin—Betamethasone—allergic rhinitis	0.000191	0.00086	CcSEcCtD
Erlotinib—Haemoglobin—Dexamethasone—allergic rhinitis	0.000191	0.00086	CcSEcCtD
Erlotinib—Haemorrhage—Dexamethasone—allergic rhinitis	0.00019	0.000855	CcSEcCtD
Erlotinib—Haemorrhage—Betamethasone—allergic rhinitis	0.00019	0.000855	CcSEcCtD
Erlotinib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	0.000188	0.000848	CcSEcCtD
Erlotinib—Arrhythmia—Triamcinolone—allergic rhinitis	0.000187	0.000842	CcSEcCtD
Erlotinib—ABCB1—lung—allergic rhinitis	0.000187	0.00271	CbGeAlD
Erlotinib—ABCG2—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000186	0.00424	CbGpPWpGaD
Erlotinib—Arrhythmia—Methylprednisolone—allergic rhinitis	0.000186	0.00084	CcSEcCtD
Erlotinib—Vomiting—Montelukast—allergic rhinitis	0.000186	0.000837	CcSEcCtD
Erlotinib—Rash—Montelukast—allergic rhinitis	0.000184	0.00083	CcSEcCtD
Erlotinib—Dermatitis—Montelukast—allergic rhinitis	0.000184	0.00083	CcSEcCtD
Erlotinib—Headache—Montelukast—allergic rhinitis	0.000183	0.000825	CcSEcCtD
Erlotinib—EGFR—Thromboxane A2 receptor signaling—ICAM1—allergic rhinitis	0.000183	0.00416	CbGpPWpGaD
Erlotinib—Mental disorder—Methylprednisolone—allergic rhinitis	0.000183	0.000824	CcSEcCtD
Erlotinib—MAP2K5—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000182	0.00415	CbGpPWpGaD
Erlotinib—Erythema—Triamcinolone—allergic rhinitis	0.000182	0.00082	CcSEcCtD
Erlotinib—ABL2—Developmental Biology—ADIPOQ—allergic rhinitis	0.000182	0.00414	CbGpPWpGaD
Erlotinib—Erythema—Methylprednisolone—allergic rhinitis	0.000182	0.000819	CcSEcCtD
Erlotinib—Malnutrition—Methylprednisolone—allergic rhinitis	0.000182	0.000819	CcSEcCtD
Erlotinib—Syncope—Prednisolone—allergic rhinitis	0.000178	0.0008	CcSEcCtD
Erlotinib—Eye disorder—Dexamethasone—allergic rhinitis	0.000177	0.000799	CcSEcCtD
Erlotinib—Eye disorder—Betamethasone—allergic rhinitis	0.000177	0.000799	CcSEcCtD
Erlotinib—Back pain—Triamcinolone—allergic rhinitis	0.000176	0.000794	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisolone—allergic rhinitis	0.000174	0.000784	CcSEcCtD
Erlotinib—Nausea—Montelukast—allergic rhinitis	0.000174	0.000782	CcSEcCtD
Erlotinib—Syncope—Hydrocortisone—allergic rhinitis	0.000173	0.000781	CcSEcCtD
Erlotinib—Loss of consciousness—Hydrocortisone—allergic rhinitis	0.00017	0.000766	CcSEcCtD
Erlotinib—Arrhythmia—Dexamethasone—allergic rhinitis	0.00017	0.000764	CcSEcCtD
Erlotinib—Arrhythmia—Betamethasone—allergic rhinitis	0.00017	0.000764	CcSEcCtD
Erlotinib—ABCB1—Allograft Rejection—FOXP3—allergic rhinitis	0.000169	0.00385	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—CYSLTR1—allergic rhinitis	0.000169	0.00384	CbGpPWpGaD
Erlotinib—Alopecia—Dexamethasone—allergic rhinitis	0.000168	0.000756	CcSEcCtD
Erlotinib—Alopecia—Betamethasone—allergic rhinitis	0.000168	0.000756	CcSEcCtD
Erlotinib—Erythema—Dexamethasone—allergic rhinitis	0.000165	0.000744	CcSEcCtD
Erlotinib—Erythema—Betamethasone—allergic rhinitis	0.000165	0.000744	CcSEcCtD
Erlotinib—ABL1—Cell Cycle—SMAD3—allergic rhinitis	0.000165	0.00375	CbGpPWpGaD
Erlotinib—Myalgia—Hydrocortisone—allergic rhinitis	0.000165	0.000742	CcSEcCtD
Erlotinib—Anxiety—Hydrocortisone—allergic rhinitis	0.000164	0.000739	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	0.000163	0.000737	CcSEcCtD
Erlotinib—Syncope—Triamcinolone—allergic rhinitis	0.000163	0.000736	CcSEcCtD
Erlotinib—Syncope—Methylprednisolone—allergic rhinitis	0.000163	0.000734	CcSEcCtD
Erlotinib—Oedema—Prednisolone—allergic rhinitis	0.000162	0.000728	CcSEcCtD
Erlotinib—Loss of consciousness—Triamcinolone—allergic rhinitis	0.00016	0.000721	CcSEcCtD
Erlotinib—Loss of consciousness—Methylprednisolone—allergic rhinitis	0.00016	0.00072	CcSEcCtD
Erlotinib—Shock—Prednisolone—allergic rhinitis	0.000159	0.000716	CcSEcCtD
Erlotinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—TGFB1—allergic rhinitis	0.000159	0.00361	CbGpPWpGaD
Erlotinib—Cough—Triamcinolone—allergic rhinitis	0.000159	0.000716	CcSEcCtD
Erlotinib—JAK3—Cytokine Signaling in Immune system—HLA-DQB1—allergic rhinitis	0.000158	0.00359	CbGpPWpGaD
Erlotinib—Oedema—Hydrocortisone—allergic rhinitis	0.000158	0.000711	CcSEcCtD
Erlotinib—EGFR—Androgen receptor signaling pathway—SMAD3—allergic rhinitis	0.000157	0.00357	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—PTGDR2—allergic rhinitis	0.000157	0.00357	CbGpPWpGaD
Erlotinib—Infection—Hydrocortisone—allergic rhinitis	0.000157	0.000706	CcSEcCtD
Erlotinib—JAK3—Signaling by Interleukins—NFKB1—allergic rhinitis	0.000157	0.00356	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—SMAD3—allergic rhinitis	0.000156	0.00356	CbGpPWpGaD
Erlotinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	0.000156	0.00355	CbGpPWpGaD
Erlotinib—Shock—Hydrocortisone—allergic rhinitis	0.000155	0.0007	CcSEcCtD
Erlotinib—Myalgia—Triamcinolone—allergic rhinitis	0.000155	0.000698	CcSEcCtD
Erlotinib—Nervous system disorder—Hydrocortisone—allergic rhinitis	0.000155	0.000697	CcSEcCtD
Erlotinib—Myalgia—Methylprednisolone—allergic rhinitis	0.000155	0.000697	CcSEcCtD
Erlotinib—Arthralgia—Methylprednisolone—allergic rhinitis	0.000155	0.000697	CcSEcCtD
Erlotinib—Anxiety—Methylprednisolone—allergic rhinitis	0.000154	0.000695	CcSEcCtD
Erlotinib—ABCB1—Allograft Rejection—HLA-G—allergic rhinitis	0.000154	0.0035	CbGpPWpGaD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	0.000154	0.000692	CcSEcCtD
Erlotinib—EPHA6—Developmental Biology—ADIPOQ—allergic rhinitis	0.000154	0.00349	CbGpPWpGaD
Erlotinib—Skin disorder—Hydrocortisone—allergic rhinitis	0.000153	0.000691	CcSEcCtD
Erlotinib—JAK3—Immune System—MS4A2—allergic rhinitis	0.000153	0.00348	CbGpPWpGaD
Erlotinib—Anorexia—Hydrocortisone—allergic rhinitis	0.00015	0.000678	CcSEcCtD
Erlotinib—Oedema—Triamcinolone—allergic rhinitis	0.000149	0.00067	CcSEcCtD
Erlotinib—Syncope—Betamethasone—allergic rhinitis	0.000148	0.000668	CcSEcCtD
Erlotinib—Syncope—Dexamethasone—allergic rhinitis	0.000148	0.000668	CcSEcCtD
Erlotinib—Infection—Triamcinolone—allergic rhinitis	0.000148	0.000665	CcSEcCtD
Erlotinib—Infection—Methylprednisolone—allergic rhinitis	0.000147	0.000664	CcSEcCtD
Erlotinib—Shock—Triamcinolone—allergic rhinitis	0.000146	0.000659	CcSEcCtD
Erlotinib—Insomnia—Prednisolone—allergic rhinitis	0.000146	0.000659	CcSEcCtD
Erlotinib—Shock—Methylprednisolone—allergic rhinitis	0.000146	0.000657	CcSEcCtD
Erlotinib—EGFR—Hair Follicle Development: Induction (Part 1 of 3)—NFKB1—allergic rhinitis	0.000146	0.00331	CbGpPWpGaD
Erlotinib—MKNK1—MAPK Signaling Pathway—NFKB1—allergic rhinitis	0.000146	0.00331	CbGpPWpGaD
Erlotinib—Nervous system disorder—Methylprednisolone—allergic rhinitis	0.000145	0.000655	CcSEcCtD
Erlotinib—Loss of consciousness—Dexamethasone—allergic rhinitis	0.000145	0.000654	CcSEcCtD
Erlotinib—Loss of consciousness—Betamethasone—allergic rhinitis	0.000145	0.000654	CcSEcCtD
Erlotinib—ABCB1—Allograft Rejection—IL13—allergic rhinitis	0.000145	0.0033	CbGpPWpGaD
Erlotinib—Skin disorder—Methylprednisolone—allergic rhinitis	0.000144	0.000649	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.000144	0.000648	CcSEcCtD
Erlotinib—Insomnia—Hydrocortisone—allergic rhinitis	0.000143	0.000643	CcSEcCtD
Erlotinib—JAK3—Signaling by GPCR—PTGDR2—allergic rhinitis	0.000143	0.00324	CbGpPWpGaD
Erlotinib—ABL1—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—allergic rhinitis	0.000142	0.00322	CbGpPWpGaD
Erlotinib—Myalgia—Betamethasone—allergic rhinitis	0.000141	0.000634	CcSEcCtD
Erlotinib—Myalgia—Dexamethasone—allergic rhinitis	0.000141	0.000634	CcSEcCtD
Erlotinib—Anxiety—Betamethasone—allergic rhinitis	0.00014	0.000632	CcSEcCtD
Erlotinib—Anxiety—Dexamethasone—allergic rhinitis	0.00014	0.000632	CcSEcCtD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000139	0.00316	CbGpPWpGaD
Erlotinib—Dyspepsia—Hydrocortisone—allergic rhinitis	0.000139	0.000626	CcSEcCtD
Erlotinib—Pain—Prednisolone—allergic rhinitis	0.000138	0.000623	CcSEcCtD
Erlotinib—Decreased appetite—Hydrocortisone—allergic rhinitis	0.000137	0.000618	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	0.000136	0.000614	CcSEcCtD
Erlotinib—Fatigue—Hydrocortisone—allergic rhinitis	0.000136	0.000613	CcSEcCtD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	0.000136	0.00308	CbGpPWpGaD
Erlotinib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000135	0.00061	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000135	0.000609	CcSEcCtD
Erlotinib—Pain—Hydrocortisone—allergic rhinitis	0.000135	0.000608	CcSEcCtD
Erlotinib—Oedema—Dexamethasone—allergic rhinitis	0.000135	0.000608	CcSEcCtD
Erlotinib—Oedema—Betamethasone—allergic rhinitis	0.000135	0.000608	CcSEcCtD
Erlotinib—ABL1—Innate Immune System—MS4A2—allergic rhinitis	0.000135	0.00306	CbGpPWpGaD
Erlotinib—Insomnia—Triamcinolone—allergic rhinitis	0.000134	0.000606	CcSEcCtD
Erlotinib—Insomnia—Methylprednisolone—allergic rhinitis	0.000134	0.000604	CcSEcCtD
Erlotinib—Infection—Betamethasone—allergic rhinitis	0.000134	0.000604	CcSEcCtD
Erlotinib—Infection—Dexamethasone—allergic rhinitis	0.000134	0.000604	CcSEcCtD
Erlotinib—ABCB1—Allograft Rejection—IL17A—allergic rhinitis	0.000133	0.00303	CbGpPWpGaD
Erlotinib—Shock—Betamethasone—allergic rhinitis	0.000133	0.000598	CcSEcCtD
Erlotinib—Shock—Dexamethasone—allergic rhinitis	0.000133	0.000598	CcSEcCtD
Erlotinib—Dyspnoea—Triamcinolone—allergic rhinitis	0.000132	0.000597	CcSEcCtD
Erlotinib—ABL2—Developmental Biology—SMAD3—allergic rhinitis	0.000132	0.00301	CbGpPWpGaD
Erlotinib—Nervous system disorder—Betamethasone—allergic rhinitis	0.000132	0.000596	CcSEcCtD
Erlotinib—Nervous system disorder—Dexamethasone—allergic rhinitis	0.000132	0.000596	CcSEcCtD
Erlotinib—Thrombocytopenia—Dexamethasone—allergic rhinitis	0.000132	0.000595	CcSEcCtD
Erlotinib—Thrombocytopenia—Betamethasone—allergic rhinitis	0.000132	0.000595	CcSEcCtD
Erlotinib—Dyspepsia—Triamcinolone—allergic rhinitis	0.000131	0.000589	CcSEcCtD
Erlotinib—Dyspepsia—Methylprednisolone—allergic rhinitis	0.000131	0.000588	CcSEcCtD
Erlotinib—MAP2K5—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	0.00013	0.00295	CbGpPWpGaD
Erlotinib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	0.000129	0.000582	CcSEcCtD
Erlotinib—Anorexia—Dexamethasone—allergic rhinitis	0.000129	0.000579	CcSEcCtD
Erlotinib—Anorexia—Betamethasone—allergic rhinitis	0.000129	0.000579	CcSEcCtD
Erlotinib—Fatigue—Triamcinolone—allergic rhinitis	0.000128	0.000577	CcSEcCtD
Erlotinib—Fatigue—Methylprednisolone—allergic rhinitis	0.000128	0.000576	CcSEcCtD
Erlotinib—JAK3—Hemostasis—IL5—allergic rhinitis	0.000127	0.00289	CbGpPWpGaD
Erlotinib—Pain—Triamcinolone—allergic rhinitis	0.000127	0.000573	CcSEcCtD
Erlotinib—EGFR—Spinal Cord Injury—IL4—allergic rhinitis	0.000127	0.00288	CbGpPWpGaD
Erlotinib—Abdominal pain—Hydrocortisone—allergic rhinitis	0.000125	0.000562	CcSEcCtD
Erlotinib—Body temperature increased—Hydrocortisone—allergic rhinitis	0.000125	0.000562	CcSEcCtD
Erlotinib—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000124	0.00282	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—IL5—allergic rhinitis	0.000124	0.00282	CbGpPWpGaD
Erlotinib—CYP1A1—Melatonin metabolism and effects—NFKB1—allergic rhinitis	0.000124	0.00282	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CYSLTR1—allergic rhinitis	0.000123	0.0028	CbGpPWpGaD
Erlotinib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000123	0.000554	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000123	0.000554	CcSEcCtD
Erlotinib—Insomnia—Betamethasone—allergic rhinitis	0.000122	0.00055	CcSEcCtD
Erlotinib—Insomnia—Dexamethasone—allergic rhinitis	0.000122	0.00055	CcSEcCtD
Erlotinib—EGFR—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—allergic rhinitis	0.000121	0.00276	CbGpPWpGaD
Erlotinib—MKNK1—MAPK Signaling Pathway—TGFB1—allergic rhinitis	0.000121	0.00276	CbGpPWpGaD
Erlotinib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	0.000121	0.000546	CcSEcCtD
Erlotinib—CYP1A1—Oxidative Stress—NFKB1—allergic rhinitis	0.000121	0.00274	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—allergic rhinitis	0.000119	0.0027	CbGpPWpGaD
Erlotinib—Dyspepsia—Betamethasone—allergic rhinitis	0.000119	0.000535	CcSEcCtD
Erlotinib—Dyspepsia—Dexamethasone—allergic rhinitis	0.000119	0.000535	CcSEcCtD
Erlotinib—Body temperature increased—Triamcinolone—allergic rhinitis	0.000117	0.000529	CcSEcCtD
Erlotinib—Abdominal pain—Methylprednisolone—allergic rhinitis	0.000117	0.000528	CcSEcCtD
Erlotinib—Decreased appetite—Dexamethasone—allergic rhinitis	0.000117	0.000528	CcSEcCtD
Erlotinib—Decreased appetite—Betamethasone—allergic rhinitis	0.000117	0.000528	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	0.000116	0.000525	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	0.000116	0.000525	CcSEcCtD
Erlotinib—ALB—Folate Metabolism—IL4—allergic rhinitis	0.000116	0.00264	CbGpPWpGaD
Erlotinib—Fatigue—Betamethasone—allergic rhinitis	0.000116	0.000524	CcSEcCtD
Erlotinib—Fatigue—Dexamethasone—allergic rhinitis	0.000116	0.000524	CcSEcCtD
Erlotinib—ABL1—Regulation of Telomerase—NFKB1—allergic rhinitis	0.000116	0.00264	CbGpPWpGaD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000116	0.00263	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—ICAM1—allergic rhinitis	0.000115	0.00262	CbGpPWpGaD
Erlotinib—Pain—Betamethasone—allergic rhinitis	0.000115	0.00052	CcSEcCtD
Erlotinib—Pain—Dexamethasone—allergic rhinitis	0.000115	0.00052	CcSEcCtD
Erlotinib—EGFR—Innate Immune System—MS4A2—allergic rhinitis	0.000115	0.00262	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—SMAD3—allergic rhinitis	0.000114	0.00259	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	0.000114	0.00258	CbGpPWpGaD
Erlotinib—Asthenia—Hydrocortisone—allergic rhinitis	0.000113	0.00051	CcSEcCtD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	0.000113	0.00257	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CYSLTR1—allergic rhinitis	0.000112	0.00254	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—PTGDR2—allergic rhinitis	0.000112	0.00254	CbGpPWpGaD
Erlotinib—Pruritus—Hydrocortisone—allergic rhinitis	0.000112	0.000503	CcSEcCtD
Erlotinib—EPHA6—Developmental Biology—SMAD3—allergic rhinitis	0.000112	0.00254	CbGpPWpGaD
Erlotinib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	0.00011	0.000497	CcSEcCtD
Erlotinib—Gastrointestinal pain—Betamethasone—allergic rhinitis	0.00011	0.000497	CcSEcCtD
Erlotinib—JAK3—Signaling by GPCR—CCL11—allergic rhinitis	0.000108	0.00246	CbGpPWpGaD
Erlotinib—Diarrhoea—Hydrocortisone—allergic rhinitis	0.000108	0.000487	CcSEcCtD
Erlotinib—Dizziness—Prednisolone—allergic rhinitis	0.000107	0.000481	CcSEcCtD
Erlotinib—Asthenia—Triamcinolone—allergic rhinitis	0.000107	0.00048	CcSEcCtD
Erlotinib—Body temperature increased—Dexamethasone—allergic rhinitis	0.000107	0.00048	CcSEcCtD
Erlotinib—Abdominal pain—Betamethasone—allergic rhinitis	0.000107	0.00048	CcSEcCtD
Erlotinib—Body temperature increased—Betamethasone—allergic rhinitis	0.000107	0.00048	CcSEcCtD
Erlotinib—Abdominal pain—Dexamethasone—allergic rhinitis	0.000107	0.00048	CcSEcCtD
Erlotinib—Asthenia—Methylprednisolone—allergic rhinitis	0.000106	0.000479	CcSEcCtD
Erlotinib—Pruritus—Triamcinolone—allergic rhinitis	0.000105	0.000474	CcSEcCtD
Erlotinib—Pruritus—Methylprednisolone—allergic rhinitis	0.000105	0.000473	CcSEcCtD
Erlotinib—Dizziness—Hydrocortisone—allergic rhinitis	0.000104	0.00047	CcSEcCtD
Erlotinib—EGFR—LPA receptor mediated events—NFKB1—allergic rhinitis	0.000104	0.00237	CbGpPWpGaD
Erlotinib—Rash—Prednisolone—allergic rhinitis	0.000102	0.000459	CcSEcCtD
Erlotinib—Dermatitis—Prednisolone—allergic rhinitis	0.000102	0.000459	CcSEcCtD
Erlotinib—EGFR—AGE/RAGE pathway—NFKB1—allergic rhinitis	0.000102	0.00231	CbGpPWpGaD
Erlotinib—Diarrhoea—Methylprednisolone—allergic rhinitis	0.000101	0.000457	CcSEcCtD
Erlotinib—MAP2K5—BDNF signaling pathway—NFKB1—allergic rhinitis	0.000101	0.0023	CbGpPWpGaD
Erlotinib—Headache—Prednisolone—allergic rhinitis	0.000101	0.000456	CcSEcCtD
Erlotinib—ABCB1—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000101	0.00229	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—ICAM1—allergic rhinitis	0.000101	0.00229	CbGpPWpGaD
Erlotinib—Vomiting—Hydrocortisone—allergic rhinitis	0.0001	0.000452	CcSEcCtD
Erlotinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—allergic rhinitis	0.0001	0.00228	CbGpPWpGaD
Erlotinib—Rash—Hydrocortisone—allergic rhinitis	9.95e-05	0.000448	CcSEcCtD
Erlotinib—Dermatitis—Hydrocortisone—allergic rhinitis	9.94e-05	0.000448	CcSEcCtD
Erlotinib—EGFR—Regulation of Telomerase—NFKB1—allergic rhinitis	9.91e-05	0.00225	CbGpPWpGaD
Erlotinib—Headache—Hydrocortisone—allergic rhinitis	9.89e-05	0.000445	CcSEcCtD
Erlotinib—Dizziness—Triamcinolone—allergic rhinitis	9.83e-05	0.000443	CcSEcCtD
Erlotinib—Dizziness—Methylprednisolone—allergic rhinitis	9.8e-05	0.000442	CcSEcCtD
Erlotinib—Asthenia—Dexamethasone—allergic rhinitis	9.67e-05	0.000436	CcSEcCtD
Erlotinib—Asthenia—Betamethasone—allergic rhinitis	9.67e-05	0.000436	CcSEcCtD
Erlotinib—ABL1—Regulation of Telomerase—TGFB1—allergic rhinitis	9.66e-05	0.0022	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—HLA-DQB1—allergic rhinitis	9.61e-05	0.00218	CbGpPWpGaD
Erlotinib—Nausea—Prednisolone—allergic rhinitis	9.6e-05	0.000432	CcSEcCtD
Erlotinib—Pruritus—Dexamethasone—allergic rhinitis	9.54e-05	0.00043	CcSEcCtD
Erlotinib—Pruritus—Betamethasone—allergic rhinitis	9.54e-05	0.00043	CcSEcCtD
Erlotinib—Vomiting—Triamcinolone—allergic rhinitis	9.45e-05	0.000426	CcSEcCtD
Erlotinib—Vomiting—Methylprednisolone—allergic rhinitis	9.43e-05	0.000425	CcSEcCtD
Erlotinib—Nausea—Hydrocortisone—allergic rhinitis	9.37e-05	0.000422	CcSEcCtD
Erlotinib—Rash—Triamcinolone—allergic rhinitis	9.37e-05	0.000422	CcSEcCtD
Erlotinib—Dermatitis—Triamcinolone—allergic rhinitis	9.36e-05	0.000422	CcSEcCtD
Erlotinib—Rash—Methylprednisolone—allergic rhinitis	9.35e-05	0.000421	CcSEcCtD
Erlotinib—Dermatitis—Methylprednisolone—allergic rhinitis	9.34e-05	0.000421	CcSEcCtD
Erlotinib—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	9.32e-05	0.00212	CbGpPWpGaD
Erlotinib—Headache—Triamcinolone—allergic rhinitis	9.31e-05	0.000419	CcSEcCtD
Erlotinib—Headache—Methylprednisolone—allergic rhinitis	9.29e-05	0.000419	CcSEcCtD
Erlotinib—ALB—Folate Metabolism—ICAM1—allergic rhinitis	9.24e-05	0.0021	CbGpPWpGaD
Erlotinib—Diarrhoea—Betamethasone—allergic rhinitis	9.22e-05	0.000416	CcSEcCtD
Erlotinib—Diarrhoea—Dexamethasone—allergic rhinitis	9.22e-05	0.000416	CcSEcCtD
Erlotinib—ABCB1—Allograft Rejection—IL10—allergic rhinitis	9.07e-05	0.00206	CbGpPWpGaD
Erlotinib—MAP2K5—MAPK Signaling Pathway—NFKB1—allergic rhinitis	8.96e-05	0.00204	CbGpPWpGaD
Erlotinib—Dizziness—Betamethasone—allergic rhinitis	8.92e-05	0.000402	CcSEcCtD
Erlotinib—Dizziness—Dexamethasone—allergic rhinitis	8.92e-05	0.000402	CcSEcCtD
Erlotinib—Nausea—Triamcinolone—allergic rhinitis	8.83e-05	0.000398	CcSEcCtD
Erlotinib—ABCB1—Allograft Rejection—IL4—allergic rhinitis	8.82e-05	0.00201	CbGpPWpGaD
Erlotinib—Nausea—Methylprednisolone—allergic rhinitis	8.81e-05	0.000397	CcSEcCtD
Erlotinib—MKNK1—Signaling Pathways—CYSLTR1—allergic rhinitis	8.76e-05	0.00199	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—TAC1—allergic rhinitis	8.65e-05	0.00197	CbGpPWpGaD
Erlotinib—Vomiting—Betamethasone—allergic rhinitis	8.57e-05	0.000386	CcSEcCtD
Erlotinib—Vomiting—Dexamethasone—allergic rhinitis	8.57e-05	0.000386	CcSEcCtD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	8.56e-05	0.00195	CbGpPWpGaD
Erlotinib—Rash—Dexamethasone—allergic rhinitis	8.5e-05	0.000383	CcSEcCtD
Erlotinib—Rash—Betamethasone—allergic rhinitis	8.5e-05	0.000383	CcSEcCtD
Erlotinib—Dermatitis—Betamethasone—allergic rhinitis	8.49e-05	0.000383	CcSEcCtD
Erlotinib—Dermatitis—Dexamethasone—allergic rhinitis	8.49e-05	0.000383	CcSEcCtD
Erlotinib—MKNK1—Signaling Pathways—CCL11—allergic rhinitis	8.46e-05	0.00192	CbGpPWpGaD
Erlotinib—Headache—Betamethasone—allergic rhinitis	8.45e-05	0.000381	CcSEcCtD
Erlotinib—Headache—Dexamethasone—allergic rhinitis	8.45e-05	0.000381	CcSEcCtD
Erlotinib—JAK3—Signaling Pathways—PTGDR2—allergic rhinitis	8.42e-05	0.00191	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HLA-G—allergic rhinitis	8.27e-05	0.00188	CbGpPWpGaD
Erlotinib—EGFR—Regulation of Telomerase—TGFB1—allergic rhinitis	8.26e-05	0.00188	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—IL5—allergic rhinitis	8.04e-05	0.00183	CbGpPWpGaD
Erlotinib—Nausea—Dexamethasone—allergic rhinitis	8.01e-05	0.000361	CcSEcCtD
Erlotinib—Nausea—Betamethasone—allergic rhinitis	8.01e-05	0.000361	CcSEcCtD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—NFKB1—allergic rhinitis	7.95e-05	0.00181	CbGpPWpGaD
Erlotinib—CYP1A2—Melatonin metabolism and effects—NFKB1—allergic rhinitis	7.9e-05	0.0018	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—TAC1—allergic rhinitis	7.85e-05	0.00178	CbGpPWpGaD
Erlotinib—ABL1—Immune System—MS4A2—allergic rhinitis	7.84e-05	0.00178	CbGpPWpGaD
Erlotinib—MAP2K5—MAPK Signaling Pathway—TGFB1—allergic rhinitis	7.46e-05	0.0017	CbGpPWpGaD
Erlotinib—JAK3—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	7.35e-05	0.00167	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—ICAM1—allergic rhinitis	7.34e-05	0.00167	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—NFKB1—allergic rhinitis	7.3e-05	0.00166	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL5—allergic rhinitis	7.3e-05	0.00166	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	7.19e-05	0.00163	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	7.13e-05	0.00162	CbGpPWpGaD
Erlotinib—ABL1—Cell Cycle—TGFB1—allergic rhinitis	6.99e-05	0.00159	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—PTGDR2—allergic rhinitis	6.87e-05	0.00156	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—NFKB1—allergic rhinitis	6.72e-05	0.00153	CbGpPWpGaD
Erlotinib—EGFR—Immune System—MS4A2—allergic rhinitis	6.7e-05	0.00152	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL5—allergic rhinitis	6.67e-05	0.00152	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—TGFB1—allergic rhinitis	6.63e-05	0.00151	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CYSLTR1—allergic rhinitis	6.61e-05	0.0015	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—IL5—allergic rhinitis	6.51e-05	0.00148	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—ADIPOQ—allergic rhinitis	6.43e-05	0.00146	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCL11—allergic rhinitis	6.38e-05	0.00145	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—PTGDR2—allergic rhinitis	6.24e-05	0.00142	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	6.22e-05	0.00141	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TAC1—allergic rhinitis	6.15e-05	0.0014	CbGpPWpGaD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	6.13e-05	0.00139	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HLA-G—allergic rhinitis	5.97e-05	0.00136	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—NFKB1—allergic rhinitis	5.85e-05	0.00133	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—NFKB1—allergic rhinitis	5.85e-05	0.00133	CbGpPWpGaD
Erlotinib—MKNK1—Disease—SMAD3—allergic rhinitis	5.75e-05	0.00131	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL5—allergic rhinitis	5.72e-05	0.0013	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—NFKB1—allergic rhinitis	5.67e-05	0.00129	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—TGFB1—allergic rhinitis	5.6e-05	0.00127	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—ADIPOQ—allergic rhinitis	5.49e-05	0.00125	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—SMAD3—allergic rhinitis	5.49e-05	0.00125	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	5.46e-05	0.00124	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CYSLTR1—allergic rhinitis	5.39e-05	0.00122	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—TGFB1—allergic rhinitis	5.31e-05	0.00121	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—NFKB1—allergic rhinitis	5.24e-05	0.00119	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCL11—allergic rhinitis	5.2e-05	0.00118	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HLA-DQB1—allergic rhinitis	5.16e-05	0.00117	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	5.08e-05	0.00115	CbGpPWpGaD
Erlotinib—UGT1A1—NRF2 pathway—TGFB1—allergic rhinitis	4.93e-05	0.00112	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CYSLTR1—allergic rhinitis	4.89e-05	0.00111	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	4.83e-05	0.0011	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—NFKB1—allergic rhinitis	4.81e-05	0.00109	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCL11—allergic rhinitis	4.73e-05	0.00107	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—TGFB1—allergic rhinitis	4.72e-05	0.00107	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—SMAD3—allergic rhinitis	4.67e-05	0.00106	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—NFKB1—allergic rhinitis	4.65e-05	0.00106	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TAC1—allergic rhinitis	4.64e-05	0.00105	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	4.61e-05	0.00105	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	4.55e-05	0.00103	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	4.34e-05	0.000986	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL5—allergic rhinitis	4.31e-05	0.00098	CbGpPWpGaD
Erlotinib—EGFR—B Cell Activation—NFKB1—allergic rhinitis	4.27e-05	0.00097	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-G—allergic rhinitis	4.24e-05	0.000963	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	4.23e-05	0.000961	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—TGFB1—allergic rhinitis	4.18e-05	0.000949	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—SMAD3—allergic rhinitis	4.02e-05	0.000915	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TGFB1—allergic rhinitis	4.01e-05	0.00091	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—SMAD3—allergic rhinitis	3.99e-05	0.000907	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	3.98e-05	0.000905	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—TGFB1—allergic rhinitis	3.79e-05	0.000861	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TAC1—allergic rhinitis	3.78e-05	0.000859	CbGpPWpGaD
Erlotinib—JAK3—Immune System—ICAM1—allergic rhinitis	3.77e-05	0.000856	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—HLA-DQB1—allergic rhinitis	3.72e-05	0.000846	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	3.7e-05	0.00084	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PTGDR2—allergic rhinitis	3.68e-05	0.000837	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-G—allergic rhinitis	3.62e-05	0.000823	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	3.61e-05	0.000822	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL5—allergic rhinitis	3.51e-05	0.000799	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—TAC1—allergic rhinitis	3.43e-05	0.000781	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL5—allergic rhinitis	3.41e-05	0.000776	CbGpPWpGaD
Erlotinib—MKNK1—Disease—CD4—allergic rhinitis	3.39e-05	0.000771	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL5—allergic rhinitis	3.2e-05	0.000728	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL5—allergic rhinitis	3.19e-05	0.000726	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—NFKB1—allergic rhinitis	3.14e-05	0.000714	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—SMAD3—allergic rhinitis	3.03e-05	0.00069	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL5—allergic rhinitis	2.92e-05	0.000663	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CYSLTR1—allergic rhinitis	2.89e-05	0.000657	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL11—allergic rhinitis	2.79e-05	0.000635	CbGpPWpGaD
Erlotinib—JAK3—Immune System—CD4—allergic rhinitis	2.77e-05	0.000629	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—ICAM1—allergic rhinitis	2.72e-05	0.000618	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HLA-DQB1—allergic rhinitis	2.64e-05	0.000601	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—SMAD3—allergic rhinitis	2.47e-05	0.000562	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD4—allergic rhinitis	2.43e-05	0.000553	CbGpPWpGaD
Erlotinib—MKNK1—Disease—TGFB1—allergic rhinitis	2.43e-05	0.000553	CbGpPWpGaD
Erlotinib—JAK3—Immune System—NFKB1—allergic rhinitis	2.39e-05	0.000542	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—NFKB1—allergic rhinitis	2.37e-05	0.00054	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DQB1—allergic rhinitis	2.26e-05	0.000513	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.19e-05	0.000498	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—NFKB1—allergic rhinitis	2.1e-05	0.000477	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD4—allergic rhinitis	2.08e-05	0.000473	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NFKB1—allergic rhinitis	2.05e-05	0.000465	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—NFKB1—allergic rhinitis	2.03e-05	0.000461	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TAC1—allergic rhinitis	2.03e-05	0.000461	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD4—allergic rhinitis	2e-05	0.000454	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TGFB1—allergic rhinitis	1.98e-05	0.00045	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—TGFB1—allergic rhinitis	1.94e-05	0.000441	CbGpPWpGaD
Erlotinib—ABL1—Immune System—ICAM1—allergic rhinitis	1.93e-05	0.000438	CbGpPWpGaD
Erlotinib—EGFR—Disease—SMAD3—allergic rhinitis	1.9e-05	0.000431	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL5—allergic rhinitis	1.89e-05	0.000429	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.85e-05	0.000421	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.82e-05	0.000415	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—NFKB1—allergic rhinitis	1.79e-05	0.000407	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—NFKB1—allergic rhinitis	1.72e-05	0.000391	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TGFB1—allergic rhinitis	1.7e-05	0.000387	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TGFB1—allergic rhinitis	1.69e-05	0.000384	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ICAM1—allergic rhinitis	1.65e-05	0.000375	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NFKB1—allergic rhinitis	1.54e-05	0.000351	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD4—allergic rhinitis	1.42e-05	0.000322	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SMAD3—allergic rhinitis	1.33e-05	0.000302	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—allergic rhinitis	1.28e-05	0.000292	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NFKB1—allergic rhinitis	1.26e-05	0.000286	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NFKB1—allergic rhinitis	1.22e-05	0.000278	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD4—allergic rhinitis	1.21e-05	0.000275	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD4—allergic rhinitis	1.12e-05	0.000254	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—allergic rhinitis	1.05e-05	0.000238	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NFKB1—allergic rhinitis	1.04e-05	0.000237	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—allergic rhinitis	9.55e-06	0.000217	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—allergic rhinitis	8.03e-06	0.000182	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NFKB1—allergic rhinitis	6.75e-06	0.000153	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—allergic rhinitis	5.62e-06	0.000128	CbGpPWpGaD
